Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 10/13/16 → 6/12/19 |
Financiación
- Sunovion Pharmaceuticals Incorporated: 508.405,00 US$
SB-STR02: A Double-Blind, Controlled Phase 2B Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients with Chronic Motor Deficit from Ischemic Stroke
- van Horne, Craig (PI)
- Quintero, Jorge (CoI)